Interestingly, IGF-1 knockdown did not alter the inhibitory effects of curcumin, suggesting that curcumin mainly acts through the IGF-2/IGF-1R pathway and downstream PI3K signaling in bladder cancer (Tian et al., 2017). The gene discussed is PIK3CB; the disease is urinary bladder carcinoma.